Cartio Therapeutics
PrivateCompany Overview
Cartio Therapeutics operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. It was founded in 2024.
Cartio Therapeutics is a biotechnology company developing chimeric antigen receptor (CAR) regulatory T cell therapies to treat atherosclerosis and other cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cartio Therapeutics Comparables
Compare Cartio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| POLYGON Therapeutics | 72% | |
| GentiBio | 71% | |
| Sonoma Biotherapeutics | 66% |
For institutional investors. Book with your work email.
Cartio Therapeutics Funding Rounds
Historical fundraising activity
Cartio Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cartio Therapeutics's valuation, stock price, and market status.
Is Cartio Therapeutics a public or private company?
Cartio Therapeutics is a private company.
What is the current stock price of Cartio Therapeutics?
Cartio Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cartio Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cartio Therapeutics worth (valuation)?
Valuation information for Cartio Therapeutics is not publicly available.
Can I buy Cartio Therapeutics stock?
Cartio Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cartio Therapeutics's last funding round?
Funding round information for Cartio Therapeutics is not publicly available.
Who are the main investors in Cartio Therapeutics?
Investor information for Cartio Therapeutics is not publicly disclosed.
Will Cartio Therapeutics IPO soon?
No public IPO plans have been announced for Cartio Therapeutics.
How can I track Cartio Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cartio Therapeutics's shares on secondary markets.